Just so we can be clear about GLP1 therapy. They reduce ad libitum energy intake via their activity on the nervous system. In the case of SEMA, ad libitum Ein is reduced by 24-35%, depending on the dose and cohort. This effect on appetite explains wt loss. doi.org/10.1016/j.molm…pic.twitter.com/FBbWvqtd0W
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 